- Q1 2024 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024€28.8 (+2.13%)Earnings
- Q4 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024€27 (+1.50%)Earnings
- Q3 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023€22.2Earnings
- Supernus Pharmaceuticals Inc R&D Day TranscriptOct 18, 2023
- Q2 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023€29 (-0.68%)Earnings
- Supernus Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023€33.2 (+0.61%)Earnings
- Q4 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2023Earnings
- Q3 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022€34.4 (+1.18%)Earnings
- Q2 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022€31.2Earnings
- Q1 2022 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2022€25.8 (-2.27%)Earnings
- Preliminary Q4 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2022€27 (-4.93%)Earnings
- Q3 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€25.6 (-0.78%)Earnings
- Supernus Pharmaceuticals Inc Acquisition of Adamas Pharmaceuticals Inc - M&A Call TranscriptOct 11, 2021
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021€22.6 (+0.89%)Earnings
- Q1 2021 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€25 (-1.57%)Earnings
- Supernus Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021€26 (+9.24%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2020€17.5 (+12.18%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 19, 2020€21.4 (+3.88%)Earnings
- Q1 2020 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€20.2Earnings
- Supernus Pharmaceuticals Inc to Acquire the CNS portfolio of Us WorldMeds LLC - Conference Call TranscriptApr 29, 2020
- Q4 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 26, 2020€17.8 (-18.35%)Earnings
- Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptNov 06, 2019€19.8 (-25.56%)Earnings
- Supernus Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019€26.27 (-7.63%)Earnings
- Q1 2019 Supernus Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019€28.06 (-17.06%)Earnings
- Supernus Pharmaceuticals Inc Investor Day TranscriptApr 16, 2019
- Supernus Pharmaceuticals Inc to Discuss the SPN-812 Phase III Topline Results - Conference Call TranscriptMar 28, 2019
- Supernus Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 13, 2019
- Q4 2018 Supernus Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2019€33.9 (+4.12%)Earnings
Supernus Pharmaceuticals Inc Investor Day Transcript
Good morning, everyone. Thank you so much for joining us today. We appreciate you making the trip and spending a good portion of your day with us. I'm Jack Khattar, President and CEO of Supernus.
Before we get started, I just want to remind everyone that we will be making forward-looking statements about the business throughout the presentation as well as the Q&A session. So please refer to the SEC filings for all the risk factors associated with our business.
We have a fairly full agenda today. I'll start very briefly with brief introductions and a brief corporate overview, and then we're going to get into the substance of today's meeting, which is our pipeline, specifically, SPN-812, SPN-810, and SPN-604. And then we will have a general Q&A session at the end.
One little detail here. After SPN-812, we will also have a Q&A session. So I will really encourage everyone to please write down your questions and, if you don't mind, no interruptions of the presentation
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)